These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6361142)

  • 1. Utilization of purified human monocytes in the agarose droplet assay for measuring migration inhibitory factors.
    Thurman GB; Stull HB; Miller PJ; Stevenson HC; Oldham RK
    J Immunol Methods; 1983 Dec; 65(1-2):41-53. PubMed ID: 6361142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Species-restricted effects of human and mouse lymphokines on macrophages.
    Tagliabue A; Mantovani A; Boraschi D; Herberman RB
    Eur J Immunol; 1980 Jul; 10(7):542-6. PubMed ID: 6157542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphokines. II. Use of horse monocytes as indicator cells for human MIF.
    Friedrich W; Lazary S; de Weck AL
    Int Arch Allergy Appl Immunol; 1976; 50(2):142-54. PubMed ID: 1107231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A system for obtaining large numbers of cryopreserved human monocytes purified by leukapheresis and counter-current centrifugation elutriation (CCE).
    Stevenson HC; Miller P; Akiyama Y; Favilla T; Beman JA; Herberman R; Stull H; Thurman G; Maluish A; Oldham R
    J Immunol Methods; 1983 Sep; 62(3):353-63. PubMed ID: 6350465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycolipid-dependent interaction between human migration-inhibitory factor and mononuclear phagocytes.
    Liu DY; Yu SF; Miller PA; Remold HG; David JR
    Cell Immunol; 1984 Oct; 88(2):350-60. PubMed ID: 6386184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage migration inhibition factor (MIF): reducing the variables.
    MacSween JM; Rajaraman K; Rajaraman R; Fox RA
    J Immunol Methods; 1982; 52(1):127-36. PubMed ID: 6288804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of assay conditions for macrophage migration from an agarose droplet.
    Fahlbusch B; Dornberger G
    Acta Biol Med Ger; 1979; 38(10):1453-60. PubMed ID: 44954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MIF-like activity of natural and recombinant human interferon-gamma and their neutralization by monoclonal antibody.
    Thurman GB; Braude IA; Gray PW; Oldham RK; Stevenson HC
    J Immunol; 1985 Jan; 134(1):305-9. PubMed ID: 3917277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An ELISA method for quantitation of macrophage migration from agarose microdroplets.
    Peck R
    J Immunol Methods; 1983 Nov; 64(1-2):179-87. PubMed ID: 6358361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Species-restriction of rat lymphoid cell migration inhibitory factor.
    Whitacre CC; Miller KC; Paterson PY
    Int Arch Allergy Appl Immunol; 1984; 73(2):108-13. PubMed ID: 6363304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Migration inhibitory factors and macrophage differentiation.
    Sorg C; Michels E; Malorny U; Neumann C
    Springer Semin Immunopathol; 1984; 7(4):311-20. PubMed ID: 6395408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of Lotus-tetragonolobus Lectin (LTL) and an MIF-like factor with guinea-pig macrophages. I. Effects on macrophage migration inhibition and receptor-binding studies.
    Fahlbusch B; Wollweber L; Drössler K; Scherbaum I; Zschiesche W
    Immunobiology; 1982 Aug; 162(3):251-64. PubMed ID: 6752005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukocyte migration inhibition in agarose.
    Hoffman PM; Spitler LE; Hsu M; Fundenberg HH
    Cell Immunol; 1975 Jul; 18(1):21-30. PubMed ID: 1095211
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro assessment of delayed hypersensitivity in the human. Inhibition of cell migration from agarose microdroplets.
    Lavergne JA; Harrington JT
    J Immunol Methods; 1978; 22(1-2):111-21. PubMed ID: 670720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of leucocyte inhibitory factor (LIF) and macrophage inhibitory factor (MIF) by PHA-stimulated lymphocytes.
    Ruthlomnitzer ; Rabson AR; Koornhof HJ
    Clin Exp Immunol; 1975 Dec; 22(3):522-7. PubMed ID: 773578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mastocytoma cell migration in vitro: inhibition by MIF-containing supernatants.
    Cohen MC; Zeschke R; Bigazzi PE; Yoshida T; Cohen S
    J Immunol; 1975 May; 114(5):1641-3. PubMed ID: 164509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractoriness to migration inhibitory factor of macrophages of LPS nonresponder mouse strains.
    Tagliabue A; McCoy JL; Herberman RB
    J Immunol; 1978 Oct; 121(4):1223-6. PubMed ID: 359704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of macrophage migration inhibitory activity by plasminogen activators.
    Roblin RO; Hammond ME; Bensky ND; Dvorak AM; Dvorak HF; Black PH
    Proc Natl Acad Sci U S A; 1977 Apr; 74(4):1570-4. PubMed ID: 193107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphokines. VI. Factors in human and other heterologous sera inhibiting the migration of guinea pig macrophages.
    Baer R; Vogt K; Lazary S; Geczy C; de Weck AL
    Z Immunitatsforsch Immunobiol; 1978 Dec; 155(2):130-43. PubMed ID: 746681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage requirement for production of guinea pig migration inhibitory factor (MIF) in vitro.
    Nelson RD; Leu RW
    J Immunol; 1975 Feb; 114(2 Pt 1):606-9. PubMed ID: 47355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.